06/16/2015
https://www.congress.gov...
"There is a difference between effective and duplicative."
"I have people in this study that are terminal, and that you are allowing the study to be able to go through, to the end, when you see an obvious effect."
"I would be glad to be able to get that, because that may broaden out and accelerate some of the process as well."
"OK. Talk to me about the internal conversation about acceptable risk."